| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药商业(元) | 409,743,638.84 | 844,582,796.29 | 439,288,623.80 |
| 医药制造(元) | 551,106,207.88 | 1,204,225,654.34 | 671,077,411.65 |
| 营业成本(元) | |||
| 医药商业(元) | 365,475,382.80 | 756,205,173.56 | 396,988,141.48 |
| 医药制造(元) | 145,299,577.01 | 318,861,539.39 | 187,216,163.82 |
| 毛利(元) | |||
| 医药商业(元) | 44,268,256.04 | 88,377,622.73 | 42,300,482.32 |
| 医药制造(元) | 405,806,630.87 | 885,364,114.95 | 483,861,247.83 |
| 毛利率(%) | |||
| 医药商业(%) | 10.80 | 10.46 | 9.63 |
| 医药制造(%) | 73.63 | 73.52 | 72.10 |
| 收入构成(%) | |||
| 医药商业(%) | 42.64 | 41.22 | 39.56 |
| 医药制造(%) | 57.36 | 58.78 | 60.44 |
| 毛利构成(%) | |||
| 医药商业(%) | 9.84 | 9.08 | 8.04 |
| 医药制造(%) | 90.16 | 90.92 | 91.96 |